asseia

Asseia is a direct-to-consumer skincare label that concentrates on “barrier-first” treatment serums and supportive essentials such as cleansers, moisturizers and SPF. All formulas are fragrance-free, dermatologist-tested and priced in the mid-range tier (€22-€48 per 30-50 ml unit). The brand sells exclusively through its own EU warehouse and global e-commerce site, with no third-party retail distribution. The line is built around patented “Tri-Ceramide Ratio 3:1:1” technology that replaces missing inter-cellular lipids in a single step, eliminating the need for separate barrier creams. Best-known SKUs include the 5 % Niacinamide + Tri-Ceramide Serum and the 0.1 % Encapsulated Retinol + Tri-Ceramide Night Fluid, both packaged in UV-blocking airless pumps. Every batch is stability-tested for 12 weeks at 40 °C and ships with a QR code that links to the COA. Customers are 25-40-year-old urban professionals who have compromised skin barriers from over-exfoliation, prescription topicals or urban pollution and want science-backed, minimalist routines. They value transparency (full INCI, % actives, pH and irritation scores posted online) and prefer cruelty-free, EU-compliant formulas over trend-driven multi-step regimens. Asseia competes in the crowded “clinical-grade” serum segment by narrowing the assortment to four SKUs that each solve two problems at once—treatment plus barrier repair—thereby cutting routine time and cost in half. Its differentiation lies in lipid-ratio IP, single-channel pricing control and post-purchase dermal educator support, positioning it between mass pharmacy brands and prestige dermatology houses.